Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
5.43
-0.79 (-12.70%)
Jun 3, 2026, 10:55 AM EDT - Market open
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $19.86 million as of June 3, 2026. Its market cap has increased by 96.63% in one year.
Market Cap
19.86M
Enterprise Value
16.55M
1-Year Change
96.63%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $65.00M to $19.86M, a decrease of -69.45%. That is a compound annual growth rate of -12.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 22.40M | 117.48% |
| Dec 31, 2025 | 10.30M | -56.90% |
| Dec 31, 2024 | 23.90M | -41.28% |
| Dec 29, 2023 | 40.70M | -47.75% |
| Dec 30, 2022 | 77.90M | -69.81% |
| Dec 31, 2021 | 258.00M | -1.86% |
| Dec 31, 2020 | 262.90M | 1,596.13% |
| Dec 31, 2019 | 15.50M | -19.27% |
| Dec 31, 2018 | 19.20M | -40.74% |
| Dec 29, 2017 | 32.40M | -50.15% |
| Jul 12, 2017 | 65.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TELA Bio | 40.74M |
| NeuroOne Medical Technologies | 30.69M |
| Cytosorbents | 30.10M |
| Pulsenmore | 28.81M |
| Modular Medical | 25.92M |
| Picard Medical | 24.93M |
| Lifeward | 21.38M |
| IRIDEX | 20.37M |